Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,158 GBX | +3.58% | +7.62% | -31.19% |
May. 23 | CVS Group says will back investigation by UK CMA into pet market | AN |
May. 23 | CVS Group Signals Cooperation for UK Watchdog's Investigation into Veterinary Sector | MT |
Sales 2024 * | 671M 855M | Sales 2025 * | 719M 916M | Capitalization | 831M 1.06B |
---|---|---|---|---|---|
Net income 2024 * | 43M 54.79M | Net income 2025 * | 52M 66.25M | EV / Sales 2024 * | 1.56 x |
Net Debt 2024 * | 219M 279M | Net Debt 2025 * | 174M 222M | EV / Sales 2025 * | 1.4 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
15.9
x | Employees | 9,100 |
Yield 2024 * |
0.68% | Yield 2025 * |
0.73% | Free-Float | 98.44% |
Latest transcript on CVS Group plc
1 day | +3.58% | ||
1 week | +7.62% | ||
1 month | +22.93% | ||
3 months | -21.86% | ||
6 months | -22.70% | ||
Current year | -31.19% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 19-11-05 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Kemp
BRD | Director/Board Member | 62 | 18-01-01 |
David Wilton
CHM | Chairman | 61 | 21-09-23 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | -.--% | ||
0.04% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,158 | +3.58% | 970,734 |
24-05-30 | 1,118 | +4.29% | 198,753 |
24-05-29 | 1,072 | +0.56% | 526,969 |
24-05-28 | 1,066 | -0.93% | 500,108 |
24-05-24 | 1,076 | +1.32% | 280,664 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVSG Stock